SCHEDULE 13G/A – Description

• Post author:andrewkaretas
• Post published:February 13, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue ReadingSCHEDULE 13G/A – Description

SCHEDULE 13G/A – Description

• Post author:andrewkaretas
• Post published:February 13, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue ReadingSCHEDULE 13G/A – Description

SCHEDULE 13G/A – Description

• Post author:andrewkaretas
• Post published:February 12, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue ReadingSCHEDULE 13G/A – Description

4: Statement of changes in beneficial ownership of securities

• Post author:andrewkaretas
• Post published:February 5, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading4: Statement of changes in beneficial ownership of securities

4: Statement of changes in beneficial ownership of securities

• Post author:andrewkaretas
• Post published:February 5, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading4: Statement of changes in beneficial ownership of securities

4: Statement of changes in beneficial ownership of securities

• Post author:andrewkaretas
• Post published:February 5, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading4: Statement of changes in beneficial ownership of securities

4: Statement of changes in beneficial ownership of securities

• Post author:andrewkaretas
• Post published:February 5, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading4: Statement of changes in beneficial ownership of securities

4: Statement of changes in beneficial ownership of securities

• Post author:andrewkaretas
• Post published:February 5, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading4: Statement of changes in beneficial ownership of securities

144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing

• Post author:andrewkaretas
• Post published:February 3, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing

144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing

• Post author:andrewkaretas
• Post published:February 3, 2025
• Post category:SEC Filings

Allogene Therapeutics, Inc.

Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing